14.27
0.56%
-0.08
Schlusskurs vom Vortag:
$14.35
Offen:
$14.51
24-Stunden-Volumen:
449.44K
Relative Volume:
0.25
Marktkapitalisierung:
$2.18B
Einnahmen:
$113.31M
Nettoeinkommen (Verlust:
$-57.51M
KGV:
-10.49
EPS:
-1.36
Netto-Cashflow:
$-20.55M
1W Leistung:
+4.39%
1M Leistung:
-3.78%
6M Leistung:
+121.58%
1J Leistung:
+164.26%
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
WVE | 14.27 | 2.18B | 113.31M | -57.51M | -20.55M | -1.36 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
2024-09-09 | Eingeleitet | JP Morgan | Overweight |
2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2023-07-05 | Eingeleitet | Raymond James | Outperform |
2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | Eingeleitet | Guggenheim | Buy |
2019-07-15 | Eingeleitet | Cowen | Market Perform |
2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
2018-08-07 | Eingeleitet | Stifel | Buy |
2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
2018-03-19 | Bestätigt | Mizuho | Buy |
2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
2015-12-07 | Eingeleitet | Jefferies | Buy |
2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Primecap Management Co. CA - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Wave Life Sciences Advances RNA Medicine Innovations - TipRanks
B. Riley Cuts Earnings Estimates for Wave Life Sciences - MarketBeat
HC Wainwright Has Pessimistic Outlook of WVE FY2024 Earnings - MarketBeat
Trading (WVE) With Integrated Risk Controls - Stock Traders Daily
Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com
Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat
Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK
Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com India
WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat
Wave Life Sciences to Present at Jefferies London Healthcare Conference - The Manila Times
What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat
US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St
Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance
Leerink Partnrs Has Bullish Forecast for WVE FY2024 Earnings - MarketBeat
Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - MarketBeat
WaVe Life Sciences's SWOT analysis: RNA editing stock faces pivotal year - Investing.com
Wave Life Sciences executive sells shares worth $576,000 By Investing.com - Investing.com Nigeria
Wave Life Sciences executive sells shares worth $576,000 - Investing.com India
Earnings call: Wave Life Sciences outlines transformative 2025 outlook By Investing.com - Investing.com Australia
Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart
Wave Life Sciences (NASDAQ:WVE) Given "Buy" Rating at HC Wainwright - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Wave Life Sciences outlines transformative 2025 outlook - Investing.com
WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wave Life Sciences’ Q3 2024 Advances in RNA Therapies - TipRanks
Wave Life Sciences: Q3 Earnings Snapshot - CT Insider
Wave Life Sciences Ltd earnings missed by $0.19, revenue fell short of estimates - Investing.com Nigeria
Wave Life Sciences price target raised to $36 from $17 at Truist - TipRanks
Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates - MSN
Wave Life Sciences files automatic mixed securities shelf - TipRanks
Q3 2024 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus.com
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Wave Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Wave Life Sciences Achieves First-Ever Human RNA Editing, Reports $310.9M Cash Position | WVE Stock News - StockTitan
WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Kno - GuruFocus.com
Privium Fund Management B.V. Purchases Shares of 48,834 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Reaches New 12-Month HighStill a Buy? - MarketBeat
Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking - Simply Wall St
WVE stock surges to 52-week high, touches $15.99 amid robust gains - Investing.com Australia
Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation - TipRanks
(WVE) On The My Stocks Page - Stock Traders Daily
Wave Life Sciences (WVE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):